RiskAverse Company
We want to introduce a new methodology for diagnosing progressive diseases Our mission is to increase the survival rate of certain disease prone populations and minimize the risk of premature death. With this in mind, our application will enhance the quality of care in the preventative phase as well as during early detection. This will significantly reduce morbidity and mortality, leading to a higher quality of life through the use of timely treatment implementation. We hope that the results obtained by the patient will lead them to make lifestyle choices that are beneficial to their health and reduce their risk for the disease.
Investor Type:
For Profit
Employee Number:
1-10
Industry:
Medical technology
Headquarters:
Boston, Massachusetts, United States
Founded Date:
2018-01-01
Technology:
Сancer Diagnostics